Wnt signaling and Dupuytren's disease.

Wnt signaling and Dupuytren's disease.

BACKGROUND: Dupuytren's disease is a benign fibromatosis of the hands and fingers that leads to flexion contractures. We hypothesized that multiple genetic and environmental factors influence susceptibility to this disease and sought to identify susceptibility genes to better understand its pa...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Dolmans, G, Werker, P, Hennies, H, Furniss, D, Festen, E, Franke, L, Becker, K, van der Vlies, P, Wolffenbuttel, B, Tinschert, S, Toliat, MR, Nothnagel, M, Franke, A, Klopp, N, Wichmann, H, Nürnberg, P, Giele, H, Ophoff, R, Wijmenga, C
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2011

Gelijkaardige items

Meta-Analysis of Genome-Wide Association Studies and Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease.
door: Kerstin Becker, et al.
Gepubliceerd in: (2016-01-01)

A genome-wide association study of Dupuytren's disease reveals 17 additional variants implicated in fibrosis
door: Ng, M, et al.
Gepubliceerd in: (2017)

Genome-wide association scan of Dupuytren's disease.
door: Furniss, D, et al.
Gepubliceerd in: (2011)

Sibling recurrence risk in Dupuytren's disease.
door: Capstick, R, et al.
Gepubliceerd in: (2013)

A genome-wide association meta-analysis implicates Hedgehog and Notch signaling in Dupuytren’s disease
door: Sophie A. Riesmeijer, et al.
Gepubliceerd in: (2024-01-01)

Surgery for Dupuytren's contracture of the fingers.
door: Rodrigues, J, et al.
Gepubliceerd in: (2015)

A weighted genetic risk score predicts surgical recurrence independent of high-risk clinical features in Dupuytren’s disease
door: Riesmeijer, S, et al.
Gepubliceerd in: (2019)

Integrative analysis of Dupuytren's disease identifies novel risk locus and reveals a shared genetic etiology with BMI
door: Major, M, et al.
Gepubliceerd in: (2019)

The role of manual occupation in the aetiology of Dupuytren's disease in men in England and Wales.
door: Khan, A, et al.
Gepubliceerd in: (2004)

Is Dupuytren’s disease really a “disease of the Vikings”?
door: Ng, M, et al.
Gepubliceerd in: (2019)

Imaging for Dupuytren disease: a systematic review of the literature
door: Sanne Molenkamp, et al.
Gepubliceerd in: (2019-05-01)

Reduced WNT4 expression in normal skin fibroblasts leads to ‘Dupuytren-like’ changes in the transcriptome
door: Aoife O'Brien, et al.
Gepubliceerd in: (2024-09-01)

Commentary on Larson et al. Genetic and environmental influences in Dupuytren's disease: A study of 30,330 Danish twin pairs
door: Furniss, D
Gepubliceerd in: (2015)

Guillaume Dupuytren
door: Romina A Parquet
Gepubliceerd in: (2013-01-01)

Dupuytren’s disease
door: Richard Trèves
Gepubliceerd in: (2011-09-01)

Dupuytren's disease
door: Rames Mattar Junior
Gepubliceerd in: (2008-03-01)

Nonsense-mediated decay and the molecular pathogenesis of mutations in SALL1 and GLI3.
door: Furniss, D, et al.
Gepubliceerd in: (2007)

Treatment for Dupuytren's disease
door: Nanchahal, J, et al.
Gepubliceerd in: (2013)

Paediatric Dupuytren's disease
door: Pradeoth Mukundan Korambayil, et al.
Gepubliceerd in: (2011-09-01)

Enfermedad de Dupuytren
door: J. M. Arandes Renú
Gepubliceerd in: (2010-11-01)

Enfermedad de Dupuytren
door: Jorge Badilla-Mora, et al.
Gepubliceerd in: (2004-10-01)

Enfermedad de Dupuytren
door: Jorge Badilla-Mora, et al.
Gepubliceerd in: (2004-10-01)

Enfermedad de Dupuytren
door: Jorge de Vecchi, et al.
Gepubliceerd in: (2020-03-01)

Dupuytren’s disease. State of the art and therapeutic perspectives
door: F.P. Cantatore, et al.
Gepubliceerd in: (2011-09-01)

Verteporfin ameliorates fibrotic aspects of Dupuytren’s disease nodular fibroblasts irrespective the activation state of the cells
door: Nataly Puerta Cavanzo, et al.
Gepubliceerd in: (2022-08-01)

Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial
door: Nanchahal, J, et al.
Gepubliceerd in: (2022)

The relationship between body mass index and the risk of development of Dupuytren's disease: a Mendelian randomization study.
door: Majeed, M, et al.
Gepubliceerd in: (2020)

Comparison of outcomes of peripheral nerve schwannoma excision in neurofibromatosis type 2 patients and non-neurofibromatosis type 2 patients: A case control study
door: Bendon, C, et al.
Gepubliceerd in: (2015)

Modern surgical management of breast cancer therapy related upper limb and breast lymphoedema
door: Leung, N, et al.
Gepubliceerd in: (2015)

Outcomes of peripheral nerve schwannoma excision in NF2 patients are as good as in non-NF2 patients - a case-control study
door: Bendon, C, et al.
Gepubliceerd in: (2013)

Dupuytren disease: prevalence, incidence, and lifetime risk of surgical intervention. A population-based cohort analysis
door: Broekstra, DC, et al.
Gepubliceerd in: (2022)

The prevalence of Dupuytren’s disease in patients with diabetes mellitus
door: Sandhya Ganesan, et al.
Gepubliceerd in: (2023-07-01)

The incidence and prevalence of Dupuytren’s disease in primary care: results from a text mining approach on registration data
door: Roel J. M. van Straalen, et al.
Gepubliceerd in: (2024-10-01)

Molecular genetics of Dupuytren’s contracture
door: Aissvarya, Shankar, et al.
Gepubliceerd in: (2024)

The molecular genetics of dupuytren disease
door: Ng, M
Gepubliceerd in: (2018)

The Hand Patient: Dupuytren's Contracture
door: U. Mennen
Gepubliceerd in: (2001-04-01)

Molecular genetics of Dupuytren’s contracture
door: Shankar Aissvarya, et al.
Gepubliceerd in: (2024-08-01)

Dupuytren’s Diathesis in an African Male
door: Richard Mbuva, et al.
Gepubliceerd in: (2016-07-01)

Needle Aponeurotomy for Dupuytren's Contracture
door: HS Cheng, et al.
Gepubliceerd in: (2008-04-01)

Heterotopic ossification in Dupuytren's disease: clinical and histological significance.
door: Sadideen, H, et al.
Gepubliceerd in: (2011)